Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...
For too long, middlemen like pharmacy benefit managers have taken advantage of the complexity of the drug supply chain to ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The Biden administration added China to its illicit drug watchlist on Monday, despite previously touting cooperation with ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback